EMQ ANSWERS
For questions on page
7
| The first 150 words of the full text of this article appear below. |
ANSWER 1
- True. Numerous studies have demonstrated that non-invasive ventilation (NIV) improves symptoms, physiological measurements and reduces intubation rates when compared with standard therapy alone.1–4
- False. The 3CPO trial failed to demonstrate a survival benefit.5 These findings are quite different from a meta-analysis published in 2005,6 which suggested a nearly 50% reduction in mortality with NIV compared with controls. However, all but two of the studies enrolled less than 100 patients. The 3CPO study enrolled more patients than all of the earlier trials combined.
- False. There is no evidence that this is true in patients with acute pulmonary oedema.6 However, most continuous positive airway pressure (CPAP) machines can deliver an FiO2 of 1.0, whereas most low-cost bilevel positive airway pressure (BiPAP) machines cannot.
- False. Although both nitrates and positive pressure ventilation will reduce preload, this does not prevent them being commenced simultaneously in patients who are not hypotensive. The 3CPO trial actively
. . . [Full text of this article]
Relevant Article
-
See page for answers
Emerg. Med. J. 2009 26: 7.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
